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Abstract
Background: Placental malaria is a disease linked to the sequestration of Plasmodium falciparum infected red blood cells
(IRBC) in the placenta, leading to reduced materno-fetal exchanges and to local inflammation. One of the virulence factors
of P. falciparum involved in cytoadherence to chondroitin sulfate A, its placental receptor, is the adhesive protein VAR2CSA.
Its localisation on the surface of IRBC makes it accessible to the immune system. VAR2CSA contains six DBL domains. The
DBL6e domain is the most variable. High variability constitutes a means for the parasite to evade the host immune response.
The DBL6e domain could constitute a very attractive basis for a vaccine candidate but its reported variability necessitates,
for antigenic characterisations, identifying and classifying commonalities across isolates.
Methodology/Principal Findings: Local alignment analysis of the DBL6e domain had revealed that it is not as variable as
previously described. Variability is concentrated in seven regions present on the surface of the DBL6e domain. The main
goal of our work is to classify and group variable sequences that will simplify further research to determine dominant
epitopes. Firstly, variable sequences were grouped following their average percent pairwise identity (APPI). Groups
comprising many variable sequences sharing low variability were found. Secondly, ELISA experiments following the IgG
recognition of a recombinant DBL6e domain, and of peptides mimicking its seven variable blocks, allowed to determine an
APPI cut-off and to isolate groups represented by a single consensus sequence.
Conclusions/Significance: A new sequence approach is used to compare variable regions in sequences that have extensive
segmental gene relationship. Using this approach, the VAR2CSA DBL6 domain is composed of 7 variable blocks with limited
polymorphism. Each variable block is composed of a limited number of consensus types. Based on peptide based ELISA,
variable blocks with 85% or greater sequence identity are expected to be recognized equally well by antibody and can be
considered the same consensus type. Therefore, the analysis of the antibody response against the classified small number of
sequences should be helpful to determine epitopes.
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Introduction
The severity of Plasmodium falciparum malaria is partially related to
alterations of the IRBC induced by parasite proteins exported to the
IRBC membrane during parasite development. Some of these
proteins confer cytoadherence properties to IRBC, leading to
parasite sequestration. The best characterized parasite adhesin is P.
falciparum erythrocyte membrane protein 1 (PfEMP1) [1], encoded
by the large polymorphic var gene family [2]. While mediating
various binding activities and representing an important target for
protective antibodies, PfEMP1 proteins undergo antigenic varia-
tion, contributing to parasite evasion of the host immune response.
Malaria during pregnancy, especially the first, is associated
with strikingly adverse effects on foetal growth (reviewed in [3]).
Pregnancy-associated malaria (PAM) parasites adhere to chon-
droitin sulphate A (CSA) [4,5], a glycosaminoglycan expressed by
the syncytiotrophoblast layer of the placenta. Several studies have
shown that a single var gene, var2csa, is highly transcribed and
expressed in both in vitro CSA-selected P. falciparum IRBC and
parasites isolated from infected placentas [6,7,8,9,10]. During
pregnancy, infected women may develop antibodies that inhibit
IRBC binding CSA, and these women appear to be protected
against PAM during subsequent pregnancies. Primigravidae lack
these antibodies, which suggests that PAM parasites express novel
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previously [4,11,12,13]. Antibody inhibition is not dependent on
the geographical origin of parasites or sera [11,14,15], indicating
that proteins mediating placental tropism are conserved or
contain shared epitopes and that a vaccine against PAM is thus
feasible. Furthermore, it has been shown that this immune
response is at least partially directed against VAR2CSA and that
antibody levels to VAR2CSA are sex- and parity-dependent.
These antibodies are associated with reduced severity of PAM
[16,17], further supporting the role of VAR2CSA as the CSA
adhesin in PAM.
Unlike other clinical malaria syndromes, PAM is associated
with a single PfEMP1 variant expressed from var2csa.T h e
var2csa gene is very particular within the var gene family: it is the
only var gene that does not include CIDR domains, being
composed of six DBL domains, three belonging to the e type
and three being unclassified (or X type) [18]. Var2csa is relatively
conserved as the sequence of each DBL domain presents
unusual homologies between parasite strains that are higher
than other var genes [9,19]. Nonetheless, the gene presents both
highly conserved and highly variable regions, leading to a
homology that varies from 54 to 94% between strains derived
from different geographical origins [7,20]. This variability is not
be due to a shift in var expression, since only one var2CSA
gene is present in most parasite strains, but rather to a
mosaic structure [20,21] generated by genetic recombination
[22].
The DBL6e domain has been described as the most
polymorphic of the six DBL domains of var2csa, with an identity
from 54 to 61% [23,24]. As suggested by Bockhorst et al. [24], this
may be partly related to a high level of epitope exposure, the
presence of hidden epitopes arising from parasite selection and the
high global variability exhibited by this domain. Epitopes present
on the IRBC surface appear to be accessible to the solvent. All
these criteria make these sequences of high interest for antibody
targets.
During pregnancy, women acquire an immune response
directed against the DBL6e domain [17]. This domain is
specifically recognized by plasma samples from pregnant women
in a parity dependant manner, being higher with multigravidae
than with primigravidae [25]. Antibodies raised against the
DBL6e domain from the FCR3 strain can bind the surface of
erythrocytes infected by PAM isolates and also inhibit CSA
binding [26]. A 30% sequence variation between two DBL6e
domains is sufficient to abolish the recognition by plasma samples
from pregnant women [25], leading to immune evasion. Similar
studies have also been performed on DBL3X [27], DBL2X
[20,23,24], and DBL5e [23]. The link between the variability of
the DBL6e domain and its immunogenicity [24,25,26] can be
correlated with immune system evasion.
Although phylogenetic trees are useful to separate various var
genes and to assign DBL and CIDR domain classes, global
alignments of this type prove to be inappropriate for the study
s e q u e n c e sw i t h i nag i v e nd o m a i nc l a s s[ 1 8 ] .L i k eB o c k h o r s t
et al. have shown for the DBL2X domain [24], we have
developed an expanded alignment to study local alignments of
variable blocks from DBL6e domains. In particular, we
developed a new graphical tool that permits discrimination
between the most frequent sequences in the parasites. The
objective of our analysis has been to classify the variable
sequences in order to understand how variability is distributed
over the DBL6e domain. This classification could be helpful for
the design
of experiments that compare all sequences found for this
domain.
Results
Amplification and sequences of DBL6e from var2csa
Sequences of the DBL6e domain from the var2CSA genes
expressed by P. falciparum placental isolates were determined by
transcription of mRNA purified from the parasitized blood cells.
Oligonucleotides representing highly conserved sequences from
the 39 end of the DBL5e domain (forward primer) and the 59
end of the ATS domain (reverse primer) were designed to
amplify the entire DBL6e domain for sequence determination.
From 24 placental parasite samples, 16 cDNA were amplified
a n dc l o n e di np C R 2 . 1p l a s m i d . For each isolate, a single
sequence was obtained, except for the 2155 isolate from
Thiadiaye, Senegal and the H852 isolate from Cotonou, Benin,
which both gave two sequences. Lengths of the extended DBL6e
( w i t hI D 5 ,I D 6 ,T Ma n dap a r to ft h eA T Sr e g i o n )s e q u e n c e d
genes ranged from 1110 to 1414 nucleotides, depending of the
i s o l a t e( T a b l e1 ) .
Table 1. Summary of sequences from strains and isolates.
Isolates Origin Accession number Length (bp)
3D7 Unknown XM_001350379.1 1403
A4 (It4, FCR3) Gambia AY372123.1 1425
KMWII Kenya EF614230.1 1229
M24 Kenya EF614231.1 1222
MC_var6 Thailand AY372127.1 1387
MTS1 Burma EF614227.1 ND*
P13 Mali EF614232.1 ND*
PC49* Peru EF614233.1 ND*
T2C6 Burma EF614225.1 1193
V1S Vietnam EF614224.1 1200
124-8 Sudan EF614229.1 1197
HB3_1 Honduras AANS01000262 ND*
HB3_2 Honduras AANS01000295 1152
CYK57 Senegal GQ848081 1371
CYK58 Senegal GQ848082 1409
CYK24 Senegal GQ848083 1374
CYK30 Senegal GQ848084 1373
CYK32 Senegal GQ848085 1387
CYK37 Senegal GQ848086 1378
CYK48 Senegal GQ848090 1378
CYK49 Senegal GQ848087 1399
CYK 51 Senegal GQ848088 1395
PAL09 Senegal GQ848089 1414
PAL10 Senegal GQ848091 1403
2155-3 Senegal GQ848092 1386
2155-4 Senegal GQ848093 1349
H839ABC Benin GQ848078 1159
H852B Benin GQ848079 1110
H852CD Benin GQ848080 1182
*Sequence too short; the carboxy-terminal region of the DBL6e is missing.
29 strains and isolates DBL6e accession number, their origin and length.
doi:10.1371/journal.pone.0011276.t001
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All DBL6e domains were aligned using the 3D7 DBL6e domain
as a reference for residue numbering (Figure 1). Most sequences
started at aa 2284. The DBL6e domain extended from G2329 to
P2651 and included 14 canonical DBL cysteine residues
numbered in bold and shown in yellow in the structural model
(Figures 1 and 2). The transmembrane segment extended from
N2677 to P2710. The length of the DBL6e domains varied from
269 to 303 residues for the isolates selected.
The global alignment (Figure 1) performed with all DBL6e
sequences (13 sequences from Senegal, 3 from Benin and 13 from
data banks (Table 1)) showed a mean APPI of 67% and 97
identical amino acid residues (27%). The variability of the DBL6e
domain is not spread randomly along the entire sequence but is
clustered in only a few blocks [24]. We clearly identified seven
highly conserved blocks alternating with seven variable blocks, as
also shown by others [24]. Three criteria were used to define the
limits of these variable blocks (VB): (i) sequence must be variable,
(ii) at least a few residues should be located in the loops of the
CYK48-DBL6e structural model and (iii) the corresponding VB
are selected as solvent exposed in the structural model. If the
variable amino acids were located in helices, as, for example, with
the amino-terminal part (TKRKELYED) and for the carboxy-
terminal part (TCVNYKN) of the VB6, they were not included as
exposed to the solvent: these sequences were considered in the
alignment, but not for the peptide synthesis. The seven VB were
aligned independently of each other (Figures 3, VB1–VB7). Their
limits are similar to those described by Bockhorst et al [24], except
for VB2, VB6 and VB7. VB2 is much longer as it included five
residues located in a structure that is exposed to the solvent in the
model (Figure 2). VB6 was much shorter and in addition we
identified a seventh VB from aa 2580 to aa 2606, corresponding to
a loop of 14 amino-acid residues flanked by a-helices that is
probably exposed to the solvent in the full-length VAR2CSA. As
suggested by Bokhorst et al., these polymorphic segments are
concentrated in flexible loops [24]. Moreover, analysing VB in the
structure model, no, or very little, secondary structure is observed.
A variable block (VB) is composed of the variable sequences
found in one region on the surface of the DBL6e domain from all
isolates. For each VB, alignment and phylogenetic trees were
generated. This revealed that each VB contained a small number
of groups of similar sequence. Each group can be represented by a
consensus sequence that is the average of all variable sequences
present within this group. Thus each VB can be represented by a
small number of consensus sequences.
An example is shown for VB1 (Figure 3 VB1, and Figure 4A),
which is random coil in the structural model. Variability within
these sequences is not due to random mutations within one
consensus sequence but to two or more well-defined consensus
sequences. Accordingly, the variability of the DBL6e domain
cannot be determined from its global APPI. A new graphic
representation of the variability that improved the assessment of
variability of these mosaic domains was developed as follows. A
curve was plotted with the threshold for the APPI between
sequences along the x-axis and the number of groups (i.e. number
of branches counted, see Figure 4A) formed by these sequences at
a given APPI threshold on the y-axis (Figure 4B). These curves
show three components of the variability: (i) the number of
consensus sequences within a VB; this number is found on the y-
axis at the inflexion point (where the slope is maximum; see
material and methods and Table 2), (ii) the variability of each
consensus sequence within its own group; this variability increases
with the difference between the ordinate at 95% and the ordinate
at the inflexion point, and (iii) how well the groups are defined and
are associated with representative consensus sequences; this is
represented by the value of the abscissa at the inflexion point
(Table 2): the level of similarity with the consensus sequence of the
isolates classified in a group increases with this value. This
representation was tested for the envelope glycoprotein of HIV
(Env), which is a highly variable protein with random point
mutations distributed along the entire gene [28]. This ‘reference
curve of variability’ gave an inflexion point at 72% APPI, with a
maximal amplitude as defined at Y (95%)–Y(60%). The set of
DBL6e sequences produced a curve typical of a highly variable
sequence (Figure 4B). The inflexion point is observed at 65% APPI
and its maximal amplitude is lower than that of Env. Only two
groups are defined at 60% but 24 groups (from a total of 26
sequences) were obtained at 95% APPI.
The sequences of the seven blocks from the 29 isolates or strains
were aligned. The VB1 sequence (2342–2368), with 25–27
residues, has no well-defined secondary structure in the structural
model. The tree (Figure 4A) has two main branches corresponding
to two widely divergent clusters of sequences. Moreover, at 85%
APPI, four groups can be distinguished. The inflexion point
(Figure 4B), is correlated with the sequence variability within each
group. Like Bockhorst et al. [24], we identified VB2 (2382–2395) as
a VB because it is present in the loop-ahelix-loop that should be
accessible to IgG, and because of its high variability (Figure 3,
VB2). However, we selected a longer sequence because an
important mutation is present (N13 to D). In Figure 4B, only
four consensus sequences occurred at APPI$85%, and the
variability of these sequences is very low (seven groups at 95%,
Figure 4B). VB3 (2415–2427), with only 13 residues length
(Figure 3, VB3) and structured as a small loop in the model, is
much more variable; the inflexion point of this curve appears at
low APPI (Figure 4B, 80%) and, moreover, the maximum
amplitude is the largest of all the curves. This VB is the most
variable and consensus sequences are not well defined since each
consensus sequence presents many mutations (21 groups at $95%,
Figure 4B). VB4 (2446–2470) is 25 residues in length and is an
ahelix-loop-ahelix in our model (Figure 3, VB4 and 2). It shares an
uncommon distribution of variability: six isolates from distant
endemic areas can be grouped (VB1-4) in a separated cluster of
identical sequences (CYK51 and PAL09 from Senegal, MTS1
from Burma, HB3_1, HB3_2 from Honduras and H852B from
Benin). Only two groups are counted at the inflexion point
($80%, Figure 4B) and 10 groups at 95%. Here again, the
consensus sequences of this VB show low variability. VB5 (2488–
2516), a random coil (Figure 2) formed by 22–29 residues, appears
even more invariable. Among the sequences represented in
Figure 3, VB5 shows a very special distribution: four very distant
clusters of sequences with a very low variability can be easily
distinguished within each group (group VB5-1 (86.1% PI; 76%
Identical Sequence (IS)): KHAYGNISHDDKKXLDIPNND-
NEH; group VB5-2 (98.7% PI; 96% IS): QKGKNNTHSEKL-
DEAWCDLPMEGDIP; group VB5-3 (95.9% PI; 93% IS):
KQAGGYKETVEKLSEKKQKCTFPDIESVP, and group
VB5-4 (85.1% PI; 59% IS): KQAGGDTKTNENCRFPD-
TDGVP). Each group has a strong signature with a very well
defined consensus sequence, representative of almost all isolates
found in endemic areas. Our graphical model cannot describe the
low variability of these sequences from VB5 since the curve does
not reflect an invariable loop (inflexion point at 75% APPI with
seven groups). VB6 (2540–2563) has 38–41 residues (Figure 3,
VB6) and forms an ahelix-loop-ahelix. We determined seven
groups at $60% and 15 groups at the inflexion point ($90%,
Table 2 and Figure 4B). VB6 has a large number of consensus
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groups are counted at 95% APPI, the inflexion point is found at a
high APPI percentage (90%). VB7 (2580–2606) of 25–27 residues
(Figure 3, VB7) forms an ahelix-loop-ahelix and has the highest
number of consensus sequences (inflexion point at 75% for 13
groups, Table 2 and Figure 4B) that are the most variable (20
groups at 95%). As with VB1, VB4 and VB5, four sequences of
VB7-1 constitute a separate group (strains and isolates 3D7,
CYK24, 124-8, CYK37, P13 and CYK51), with consensus
sequences that are very different from the others within this VB.
Even though our analysis using a graphical representation of
variability is more relevant than the percentage identity as is
commonly used, it did not allow the extent of variability of VB5,
VB6 or VB7 sequences to be determined. The number of groups
defined at the inflexion point (Table 2) is not fully relevant with
regard to the true variability. We therefore generated a Variability
factor (VF) histogram (Figure 4C). The VF was calculated by
dividing the difference between the number of groups defined at
60% and 95% APPI, and the inflexion point on the X axis (the
threshold where variable sequences within one group formed share
low variability, see Table 2). Ordinates were normalized by the
number of the sequences analyzed (29 for VB1, VB2, VB3, VB4
and VB5; 28 for VB6; 27 for VB7; 26 for DBL6e and 33 for Env).
Because the VF is a combination of 3 independent variables
characterising the curve in Figure 4B (see above), it is more
relevant for analysis of the invariability of each VB. As positive
control, we calculated the VF for the envelope protein ‘Env’ from
HIV (1.35), which is a highly variable protein. The highest value of
VF was calculated for the DBL6e domain (1.41); the least variable
sequence was VB2 (0.24). As we previously concluded, VB5 is not
variable, having a low VF (0.37). The VF of VB3 (0.73) was very
high, as was that of VB7 (0.89). With an VF of 0.59, VB6 is clearly
not as variable as expected from its global APPI of 45%. Such
apparently discrepant results arise from the fact that a large
number of consensus sequences is indicated (Figure 4C), but these
sequences are almost invariant. Here we have therefore developed
two graphical approaches that together allow groups of sequences
with more than one consensus sequence to be correctly analysed.
Finally, geographically distant isolates can share the same
sequence, even with 100% APPI. Some sequences from VB1-4 are
the same in Peru (PC49), Benin (H852B), and Senegal (CYK57));
the VB5-3 of strains from Kenya (M24), Burma (MTS1), Senegal
(PAL10 and CYK48), and Benin (H852CD) have exactly the same
sequence. Moreover, we did not find any country where all
variable sequences share low variability and are represented by a
single consensus sequence. These observations suggest that the
groups of sequences and molecular signatures are independent of
geographical origin and, consequently, that polymorphisms
present in different parasite isolates evolved before the transcon-
tinental spread of P. falciparum. These results should be confirmed
with a larger number of sequences.
Expression and purification of the CYK48-DBL6e domain
Baculovirus was generated by homologous recombination
between a plasmid carrying the DBL6e gene and the linear
baculovirus genome. After three virus amplifications and protein
expression in insect cells, a two-step purification was performed.
After passage over a cobalt gel column, a gel filtration purification
step was carried out to remove remaining contaminants. The
reduced 42 kDa domain (and non-reduced domain, data not
shown) was observed on an acrylamide gel with an apparent
molecular weight of 50 kDa and at least 90% purity (Figure 5 lane
1). A quantity of 400 mg of the domain was purified from 0.5 L of
baculovirus-insect cells supernatant.
Plasma samples recognition and CYK48-DBL6e
antigenicity
Experiments were designed to determine the percentage of
plasma samples reacting against CYK48-DBL6e and peptides
based upon the seven variable blocks in this sequence. First, we
investigated the reactivity of 80 plasma samples from primigravid
or multigravid women. Plasma samples from non-exposed women
and men were assessed as negative control. Plasma sample
responses from exposed pregnant women were significantly higher
than non-exposed men and women (Kruskal-Wallis test:
p=0.014). The response also increased with parity (p,10
24).
We purified and quantified IgG from 96 plasma samples. The
concentrations of protein G-purified IgG varied from 0.23 to
0.98 mg/ml per 30 ml of plasma sample. Purity of the IgG is
shown on Figure 5 where non-reduced IgG (150 kDa) is in lane 2,
and reduced IgG (heavy chain, 50 kDa and light chain, 25 kDa) is
in lane 3. We followed the reactivity against the DBL6e-CYK48
domain with two positive and two negative plasma samples at
various concentrations (data not shown). We determined the
threshold concentration needed to produce a significant signal at
20% of the apparent avidity constant to be 0.0205 mg IgG/mL.
This concentration was used in ELISA experiments with peptides
mimicking the variable blocks.
VB recognition and correlation between frequency
recognition of sequences by plasma samples and
prevalence of DBL6e VB sequences within the population
Our principal aim was to correlate the number of isolates
sharing identical sequences of various VB at different APPI, and
the percentage of plasma samples reacting against each VB. We
performed ELISA experiments with synthetic biotinylated pep-
tides. All were recognized by one or more plasma samples. No
single peptide reacted with all purified IgG samples, and no single
IgG sample reacted with all peptides, indicating that the responses
are specific with very low experimental noise. Purified IgG from
women and men from non-endemic areas recognized a mean
(6SD) of 0.60 (60.74) peptides, while primigravidae, secongravi-
dae, and multigravidae recognized 1.79 (61.17), 1.64 (61.05), and
2.37 (61.33) peptides, respectively, from the seven VB peptides
tested by ELISA. As shown on Figure 6, the peptide from VB1 was
recognised by more plasma samples (median=0.32) than other
(median=0.15 to 0.25). VB1 and VB4 from CYK48-DBL6e were
the most frequently recognised of the seven VB studied from this
isolate, with 63% and 35% of pregnant women plasma samples,
respectively, recognising these sequences (Table 3). Sequences
from VB1 and VB4 were present (at APPI.85%) in 48 and 46%
of the parasite isolates, respectively (Table 3).
Figure 1. Alignment of the entire sequence of the DBL6e domain from various isolates. With respect to the 3D7 PFL0030c residue
numbering and combined the alignment, ID5 is located from M2287 to K2328, DBL6e from G2329 to P2651, transmembrane domain from N2677 to
P2710 and ATS from K2711 to the C-terminus. The highly conserved amino acids are coloured in red, the lowly conserved amino acids are in blue, and
the highly variable amino acids are in black. The seven polymorphic blocks are highlighted in gray. At the top of the sequences, cysteine residues are
numbered from 1 to 12 in bold. (*) indicates the sequence of the expressed and purified CYK48-DBL6e domain. On the left, all strains and isolates are
presented; all are listed in Table 1.
doi:10.1371/journal.pone.0011276.g001
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sequence recognition by the plasma samples and the prevalence of
DBL6e VB sequences within the parasite population. VB1 to VB7
of CKY48-DBL6e were recognised by 63, 20, 13, 35, 16, 21, and
29% of plasma samples, respectively (Table 3). The percentage of
isolates sharing each VB sequence with CYK48-DBL6e at various
APPI (80, 85, 90, and 95%) was plotted in Figure 7. For VB1, at
thresholds of 80, 85, 90, 95% of APPI, respectively, 54, 54, 39 and
18% of isolates shared the same sequence. We determined these
values for the remaining VB and plotted the threshold for the
average identity between sequences for each loop (x axis) against
the percentage of plasma samples that recognise the CYK48-
DBL6e domain (y axis) and the curve was fitted by linear
regression. The correlation coefficient (Pearson’s r) was deter-
mined for all VB at four APPI thresholds (80, 85, 90, and 95%).
The highest correlation coefficient (r=0.74) was obtained at 85%
PI, suggesting that, in our assay, two women infected by two
parasites sharing a VB with at least 85% APPI should have plasma
samples that react to the consensus sequence tested. This
observation allows a classification of the VB sequences and to
group those that share at least 85% of APPI. This classification
allows the consensus sequences representing groups of sequences
to be identified. In our ELISA assay, the reactivity of plasma
samples to a given consensus sequence of a group was
representative of responses to each of all sequences from this
group.
Once this threshold was determined, we re-examined the trees
and groups formed, counted the number of groups and
determined the consensus sequences that were representative of
all VB sequences found in endemic areas. This classification
allowed us to determine that, for VB1, 2, 3, 4 and 5, only four or
five consensus sequences with at least 85% APPI are representative
of each VB found in the DBL6e isolates sequenced (Table 4). For
example, four consensus sequences were identified for VB1 that
represent groups formed with 98.6, 89.7, 88.5, and 86.1% APPI.
These groups represent 17, 24, 10 and 48% of the parasites
studied, respectively, and thus essentially 100% of the parasite
sample. The other VB showed similar characteristics, suggesting
that these sequences effectively represent all existing sequences.
Groups formed by VB6 and VB7 are less relevant as eight and
three consensus sequences are representative of 80 and 63% of the
parasite isolates, respectively.
Finally, we tried to correlate the response of plasma samples
with the VB sequences of the DBL6e domain isolated from the
same woman (i.e. matched plasma sample and sequence). The
reactivity of 11 plasma samples against the VB5 from CYK48-
DBL6e was assessed (see Table 5 for loop 5). The matched plasma
sample (woman CYK48) did not react against the DBL6e-CYK48
domain. Plasma sample from patient PAL10, whose parasite had
exactly the same VB5 sequence, reacted strongly with CYK48
VB5 sequence. This response variability was observed in many
individuals, and did not appear to be related to parity.
We initially hypothesised that two individuals infected by
parasites sharing at least one identical VB sequence should present
IgG that recognize the DBL6e domain. In fact, recognition of a
given VB by a plasma sample was not related to the DBL6e
sequence encountered at delivery. Two hypotheses may account
for these observations. First, an early infection in pregnancy may
induce an effective antibody response that, in turn, leads to
parasite clearance. Second, an infection occurring very late in
pregnancy will not be able to induce a specific antibody response
at delivery. Both possibilities would lead to a lack of correlation
between the DBL6e sequence present at delivery and the specific
antibody response. Such findings are in agreement with previous
work [29,30], which showed that women exposed to malaria do
not acquire VSA-PAM-specific antibodies earlier than halfway
through their first pregnancy. Similar phenomenon can be
transposed to multiparous women, in which multiplication of
parasites requires that these parasites express new epitopes
unknown for this woman.
Discussion
Many studies have addressed the variability of VAR2CSA
sequences. Although most have studied variability at the level of
the entire domain, a few studies have investigated the basis of
variability of DBL domains in depth [20,23,24,27]. Here, we have
described DBL6e, the most variable of the six DBL domains of the
VAR2CSA adhesin. This domain is of particular interest and
relevance as it is subjected to an uncommonly high selection
pressure. After alignment and tree analysis of complete DBL6e
domain sequences, no consensus sequence is evident. As already
observed, further detailed DBL6e sequence analysis reveals that
these domains are mosaics constituted of highly conserved blocks
alternating with seven highly variable blocks on the surface of the
structure model. Local alignment analysis of these variable blocks
revealed that their variability is not due to random mutations on a
single consensus sequence. In each VB, four or five groups are
represented by a highly conserved consensus sequence that
emerges from alignments, their permutation generating the high
DBL6e variability. Within these groups, variability is introduced
by insertions, deletions or by conservative mutations.
We performed alignment and tree building to elaborate a new
approach to analyse the variability of sequences presenting more
than one consensus sequence. Graphical and histogram represen-
tations, combined with ELISA experiments, allowed identification
of these groups and their representative consensus sequences, and
evaluation of their variability. Most VB are weakly variable since
only a few mutations were observed within their consensus
sequences, as observed for VB5. For VB6, eight consensus
sequences that represent only 80% of the parasites were counted
but only few residues are mutated within each group. VB3 is the
most variable since five consensus sequences were found with low
APPI (Table 4). The high variability apparent in the DBL6e
domain is due to three factors: the mosaicity of its sequence, the
presence of various consensus sequences and the low variability
within the groups. We determined the most frequent consensus
sequence in the population. The study of all consensus sequences
of each VB will allow determining which one should be
dominantly recognised by antibody. Finally these results should
simplify future research of dominant epitopes by reducing the
number of possible sequences to be studied.
We studied the reactivity of plasma and purified IgG from
pregnant women against a recombinant DBL6e domain from a
placental isolate and seven peptides mimicking the variable blocks
from this domain. Most plasma samples from infected pregnant
Figure 2. Structure model of CYK48-DBL6e domain. This structure was performed with HHMM software using the DBL6e (2WAU) domain of
Kundrae et al as template. This model was used to determine the limits of variable blocks and to design relevant peptides. Cysteine residues are
shown in yellow and variable blocks on the surface of the domain are in red. Conserved sequence is coloured in gray and is located in the core of the
domain.
doi:10.1371/journal.pone.0011276.g002
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PLoS ONE | www.plosone.org 7 June 2010 | Volume 5 | Issue 6 | e11276Figure 3. Alignment of the variable blocks. Alignments of variable blocks VB1, VB2, VB3, VB4, VB5, VB6 and VB7 shows that consensus sequence
groups within each VB are limited in number. The sequence of CYK48-DBL6e is indicated by (*). Green: 100% similar; khaki: 80 to 100% similar;
Orange: 60 to 80% similar; Gray: less than 60% similar.
doi:10.1371/journal.pone.0011276.g003
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PLoS ONE | www.plosone.org 8 June 2010 | Volume 5 | Issue 6 | e11276Figure 4. Graphical representation of the low VB variability. A: Trees were generated for each of the variable blocks in DBL6e, branch
annotations are the average percent pairwise identity (APPI) for VB1 sequences in this subtree. B: For various APPI (on the x-axis), branches (i.e.
groups) are counted and marked on y-axis. Graphic representation of variability of the DBL6e domain (black circle), the envelope protein of HIV
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recognised by at least one of the plasma samples and most plasma
samples recognised at least one peptide. Thus, synthetic peptides
were able to mimic at least linear epitopes present within VB.
Although the presence of conformational epitopes in the DBL6e
domain cannot be excluded, this does not invalidate our data
obtained with peptides. This study demonstrates that VB are
immunogenic and recognized by maternal antibodies. The likely
cause of variability of the VB comes from a selection pressure due
to their accessibility to antibodies, as suggested by the DBL6
model.
We analysed the occurrence of VB consensus sequences from
the DBL6e domain, hypothesising that this distribution does not
vary geographically. We compared the prevalence of each
sequence in the parasite population with the percentage of
pregnant women plasma samples, from Benin and Senegal,
recognizing it. We found a strong correlation tolerating at least
85% of APPI in our ELISA assay. At this threshold, these
sequences could be described by a single consensus sequence
representing the group and can thus be considered as an identical
epitope. A high number of plasma samples and sequences
originating from a given endemic region should increase the
accuracy of the data. Additional data relating sequences and their
recognition by plasma samples should confirm whether antigenic
sequences vary geographically.
These sequences within the domain present neither secondary
structure nor well defined highly compact structure, as suggested
by Bockhorst et al. [24]. Some VB structures could not be traced in
the DBL6e-3D7 crystal structure: any two VB lacking an
energetically stable structure cannot significantly effect on each
other. Moreover, all VB are very distant from each other in the
DBL6e structure, preventing interactions between them. No
structural changes can be transmitted from one VB to the other
because most cysteine residues forming cystine bridges lock the
structure, and prevent structural deformations. The presence of
two consensus sequences in two VB are never correlated (perhaps
due random permutation of VB). All these indications affirm that
the VB are completely independent within the DBL6e domain.
Because each VB presents a maximum of four to five
independent consensus sequences (Table 4), the seven VB
sequences of each sequenced DBL6e domain can be represented
by the VB sequences from only five DBL6e domains. Conse-
quently, studying the immunogenicity of five domains should
represent all DBL6e tolerating at least 85% APPI.
Many studies by different groups have given divergent results.
This apparent discrepancy may result from the fact that the FCR3
and 3D7 strains used by most laboratories differ from wild isolates
[25] as well as they differ from each other; the resulting immune
response may therefore diverge. We confirmed that two DBL6e
from two strains or isolates are highly unlikely to share the same
sequence. Since this variability leads to immune system evasion, it
is difficult to compare studies performed with DBL6e domains
from different isolates because our results suggest that any given
DBL6e induces antibodies that react only with sequences from
each of the seven VB of this isolate. As each VB exhibits only four
or five distinct consensus sequences, the likelihood that a VB
expressed by a new parasite has been previously encountered by
the individual increases with the number of preceding infections.
Each new infection will move the VB antigenic repertoire towards
completion, but given the reduced number of possible consensus
sequences at each VB level, the entire repertoire should be rapidly
encountered after first pregnancies, in line with the frequent
observation of anti-VAR2CSA antibodies in multiparae.
Our approach is one of the first to study short sequences from a
DBL domain. The first studies aimed to classify and group DBLa
(purple triangle), VB1 (blue square), VB2 (black diamond), VB3 (green triangle), VB4 (red diamond), VB5 (gray square), VB6 (light blue triangle) and VB7
(orange circle). In C, a histogram was constructed to determine the variability of the various blocks composed of more than one consensus sequence.
HIV represents the histogram obtained with the Env glycoprotein of HIV. For comparison, global APPI of all the sequences are indicated at the top of
each histogram.
doi:10.1371/journal.pone.0011276.g004
Table 2. Characteristic values of curves.
Sequence Y (60%) Y (95%) X (IP*)
Number of groups
at 85% APPI
DBL6e 22 4 6 5 2 0
Block 1 1 12 85 4
Block 2 2 7 85 4
Block 3 1 21 80 8
Block 4 1 10 80 6
Block 5 3 11 75 7
Block 6 7 20 90 14
Block 7 1 20 75 13
*Inflexion Point, where the slope of the curve is maximum.
Number of groups (Y value) at critical points (60 and 95%) and variability of
consensus sequence (X value at the inflexion point (IP)). These values have been
determined from the graphics on Figure 4B. The histogram was constructed
using the following equation: [Ynorm(95%)2Ynorm(60%)]/X(IP) to describe the
variability of a sequence where more than one consensus sequence is found.
doi:10.1371/journal.pone.0011276.t002
Figure 5. Purity of various proteins. CYK48-DBL6e domain and
antibodies observed after purification on 10% acrylamide gel (Invitro-
gen) stained with Coomassie blue. Reduced CYK48-DBL6e domain (lane
1) after two purification steps and non-reduced or reduced antibody
from protein G purification (respectively lanes 2 and 3). Molecular
weight on left lane (Biorad).
doi:10.1371/journal.pone.0011276.g005
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[24]. We did not compare all DBLe domains within parasites since
DBL6e was amplified with a downstream primer located in the
ATS of the transcribed var2csa gene in parasites isolated from
infected placentas. Like Bull et al. [31] with PoLV 1–4 sequences,
we used positions of ‘limited variability’, described as highly
variable sequences, to classify DBL6e sequences. This classification
should help for future experiments on a restricted number of
potential immunogenic sequences.
A relationship between the occurrence of given consensus
sequences in the parasite population and the frequency of reacting
plasma samples in the human population from the same area
indicates that these consensus sequences are still expanding. At the
end of the expansion of a sequence, most people have acquired
antibodies against strains sharing a given epitope, leading
eventually to the disappearance of the strains expressing this
sequence in pregnant women. Therefore, an imbalance between
the proportions of positive serum and the occurrences of sequences
should be observed.
These findings should allow, in future experiments, testing the
potential dominance of epitopes formed by a small number of
consensus sequences found in all variable blocks with PAM-specific
IgG in order to ascertain the sequences representing dominant
epitopes. A combination of antibody may be required to be
protective, eventually involving antibodies against DBL6e but also
against other DBL of VAR2CSA.Finally, this should aid the
identification of the most antigenic and immunogenic epitopes on
the surface of the DBL6e domain that would constitute an effective
pregnancy-associated malaria vaccine. The approach described here
can be applied to the other DBL domains of VAR2CSAto determine
if these conclusions also extend to other regions of this variant.
Materials and Methods
Sample collection
Samples were collected in Senegal and Benin as part of studies
of P. falciparum-infected pregnant women in Thiadiaye in 2001
[32], and Pikine-Gue ´diawaye in 2003–04 [33], Senegal, and in
Cotonou, Benin in 2006–2007 [34]. At parturition, malaria
infection was assessed by examination of placental blood smear by
microscopy. Total RNA from IRBC containing trophozoite/
schizont stage parasites from placental blood was prepared using
organic extraction from Trizol [6]. Plasma samples were isolated
and stored at 220uC until use. The National Ethics Committee of
the Senegalese Health Ministry and the Science and Health
Faculty Ethics Committee in Benin approved these studies.
Written informed consent for data and blood collection and
storage was obtained from all subjects before enrolment in the
study. Thick and thin smears of blood from both the maternal side
of the placenta and peripheral venous blood were Giemsa stained
and examined for the presence of parasites, pigment.
Cell lines
Insect cells (Spodoptera frugiperda 9 [Sf9]) were maintained at 27uC
in TC-100 medium (Invitrogen) containing 2 g/mL glucose,
Figure 6. Reactivity of purified IgG against variable blocks. The
level of purified IgG responses expressed as optical density (OD) units at
450nm against the various peptides is shown for women at delivery
living in endemic area. The top, bottom, and middle lines of the box
correspond to the 75th percentile, 25th percentile, and 50th percentile
(median), respectively. The whiskers extend from the 10th percentile
and top 90th percentile.
doi:10.1371/journal.pone.0011276.g006
Table 3. Synthesised peptide sequences from CYK48-DBL6e VB1 to 7.
VB Sequences of peptides from isolate CYK48 % of isolates* Reactivity of IgG
1 Localisation
1 B-AhxGGIHDRMKKNNGNFVTDNFVKNSWEISN-Ct
$ 48 63 2342–2368
2 B-AhxGGNIKDTQICQYKRDP-Ct 29 20 2382–2395
3 B-AhxGGLKIVYGEAKTKVAHAM-Ct 14 13 2415–2427
4 B-AhxGGENNSSDKIGKILGGDGDRKNEKRKA-Ct 46 35 2446–2470
5 B-AhxGGKQAGGYKETVEKLSEKKQKCTFPDIESVP-Ct 17 16 2488–2516
6 B-AhxGGVQKICASAECNTSNGSVDKAECTK-Ct 11 21 2540–2563
7 B-AhxEIQKNKYDTEFKNQNGNHKDAPDYLKE-Ct 40 29 2580–2606
*Identical at 85% of average percentage pairwise identity.
1In % on 80 purified IgG.
$B: Biotin; Ct: Carboxyterminal.
Sequence of variable blocks from CYK48-DBL6e. For example, the number of isolates identical to CYK48 VB1 determined from Figure 4B. At the branch where APPI.85%
(here 86.1%), 14 strains are counted (for a total of 29 strains: 48% of them have the same sequence at APPI.85%). The other VB values were determined as the same
way.
doi:10.1371/journal.pone.0011276.t003
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High Five (HF) cells (Invitrogen) were grown at 27uC in Insect
XPress medium (Cambrex).
DBL6e domains sequenced from placental isolates
The various DBL6e domains were amplified from cDNA of
placental isolates after RNA extraction and reverse transcription,
as previously described [6]. Primers were designed to amplify all
DBL6e domains from var2csa. The forward primer containing the
BamHI sequence was complementary to a highly conserved DNA
sequence within the 39 part of the DBL5e domain (DBL6F: 59
CATTGTTCTAAATGTCCGTGTGGA 39). The reverse primer
containing the PstI sequence was complementary to a highly
conserved DNA sequence within the 59 region of the ATS domain
(59 DBLRev3: TTCGGAGGAAGTTATATCAGAGGA 39). The
high fidelity Taq polymerase phusion (Finnzymes) was used with
the following PCR program: 94uC–7min, (94uC–30sec, 49uC–
30sec, 68uC–2min) 5 times, and (94uC–30sec, 57uC–30sec, 68uC–
2min) 30 times, then 68uC–7min. After digestion and insertion in
the pCR2.1 plasmid, the insert of four clones was sequenced using
a sequencing kit big dye terminator v1.1 (Applied biosystems). The
chromatograms were obtained with an ABIprism 3100 sequencer.
The software multalin (http://bioinfo.genotoul.fr/multalin/
multalin.html) was used with the default settings to align the
DNA sequences of the DBL6e domains.
DBL6e sequences analysis: protein alignment,
phylogenetic tree, and pairwise identity
Sequence alignment of was performed with ‘genious 4.6.2’
software, the plugin ‘muscle’ (http://www.geneious.com/) and
BLOSUM62 matrix. Since the entire sequence of the domain was
required for a good alignment, only 26 sequences for which the
complete sequence was available were used. For most of the blocks,
29 sequences were available. Trees were generated with the same
software using the genetic distance model of Jukes-Vantor with the
‘Unweighted Pair Group Method with Arithmetic mean’(UPGMA)
tree build method. Average percent pairwise identity (APPI) was
determined for each group. At various APPI thresholds ($60, 65,
70, 75, 80, 85, 90 and 95%), values were plotted on x-axis against
the number of groups counted at each of these values on the y-axis.
The number of sequences aligned was variable: for the overall
DBL6e domain sequence, 24 sequences were used, while sequences
from blocks 1–5 came from 27 isolates, and those from block 6–7
came from only 26 isolates. All accession numbers are given in
Table 1. Transmembrane domains were detected with the software
http://www.cbs.dtu.dk/services/TMHMM-2.0/.
From the tree in Figure 4A, a curve was constructed by
counting the number of sequence groups that formed when the
sequences were clustered into groups by their APPI. As an
example, for VB1 (blue squares) less than 60%, all sequences are
grouped because the global APPI identity is 65.4%. There is a
total of 29 sequences in the tree for VB1, so the maximum number
of groups is 29 (all sequences form their own group). The y-axis
gives the percentage of possible groups for a given APPI threshold,
which at the 60% pairwise cut-off is 1/29 (or 3.5%). At the other
end of the plot for 95% identity there are 11 groups for VB1 (11/
29 or 38%). The number of groups can be derived by sectioning
the tree vertically, where all branches cut are either terminal
branches or have APPI.95%. The curve is generated by
computing the group percentage for a variety of thresholds on
APPI. This method is used to draw the curves for all VBs, the
whole DBL6e domain, and the HIV env.
Figure 4B is a synthesis of the trees constructed for all VB.
These curves have been drawn to identify true sequence variability
Figure 7. Graphic representation of the variability tolerated for a sequence that remains dominant epitope at various identity
percentages. Experimental responses of purified IgG against the VB are shown in percent on the x-axis and are summarised in Table 3 (Reactivity of
IgG). The occurrence of each VB sequences in the population was counted. For example, in Figure 4B at APPI.85% (here 86.1%) we counted 14
strains (or 14/29*100%). In Figure 4, the number of sequences identical to CYK48 (indicated with*) were counted. Percentage of isolates with the
same sequence as CYK48 for each VB is indicated on y-axis at 80% (black circle), 85% (blue square), 90% (green triangle), or 95% (red diamond) APPI.
For example, see values for APPI=85% in Table 3 (% of isolates). Experimental distribution around the linear curve is linked to the APPI tolerated to
have an identical IgG response to two sequences. The best Pearson’s r (0.74) for a linear model is calculated for 85% APPI. This graph indicates a cut-
off of 85%. In our ELISA, two sequences sharing this APPI will have the same antibody response.
doi:10.1371/journal.pone.0011276.g007
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APPI are plotted on the x-axis and the number of groups counted
at each APPI value is plotted on the y-axis. At APPI,the inflexion
point, branches are very distant and the variable sequences are
very different. At APPI.the inflexion point, sequences share a low
variability between themselves and can thus be represented by a
single average sequence.
Figure 7 was constructed as follows: for VB1, for example, the
number of sequences identical to CYK48 was counted. On the
branch where APPI.85% (here 86.1), 14 strains (for a total of 29,
i.e. 48%) are in the same group, represented by a single consensus
sequence. The calculated values for all VB are on the y-axis (see
example for VB1 in Table 3, % of isolate at APPI.85%). The
percentage of positive IgG against the VB are on the x-axis. We
compared the curve fit (linear regression) for the four curves
following Pearson’s r. We BLASTed these VB sequences and
found no human protein with a high score and low E value.
Construction, expression, and purification of the
recombinant CYK48-DBL6e domain and peptides design
and synthesis
The CYK48-DBL6e domain sequence was cloned from a
Senegalese placental isolate and DBL6e was obtained by PCR with
the following specific primers: FID5AN: 59 CAGTCGGATCC-
TATGCAAGAAATAGCTAACAATAAAG 39,a n dR I D 6 K S :5 9
GTCGCCGCTGCAGTTAATGGTGATGGTGATGGTGGT-
CCTCCAGAGTTTCATAAGGATTT 39 on the plasmid pCR2.1
carrying the ID5-DBL6-ATS DNA fragment sequenced. After
BamHI and PstI digestion, the DBL6e DNA PCR product was
ligated into the pAcGP67A plasmid (BD bioscience) and fused with
the GP67 secretion signal sequence at the amino-terminus and with
a C-terminal hexa-histidine tag. As described in the manufacturer’s
protocol, the constructwasco-transfected with the baculovirus linear
DNA (BD bioscience) into Sf9 cells in the presence of Cellfectine




VB1-1 LYSRMQHNIDTIWTDLLVKNSSDINK 98.6 17 100
VB1-2 INVNMKKNNDNIWTDLLVKNSSDINK 89.7 24
VB1-3 INVNKRHKNDDTFVTDNFVKKSWEISN 88.5 10
VB1-4 IHDRMKKNNGNFVTDNFVKNSWEISN 86.1 48
VB2-1 NIKDTQICQYKRDPKL 96.4 24 100
VB2-2 YIDPSKICEYKKNPKL 95.3 28
VB2-3 KIDZSDICEYKKDPKL 87.1 21
VB2-4 NIEKSDICKYKKNPKL 93.1 28
VB3-1 IVYRQDKEKVAN 94.4 10 93
VB3-2 KLYPKDRAKVVH 84.1 24
VB3-3 NVYGEAKTKVAH 84.1 24
VB3-4 KAYGGARAKVVH 91.7 7
VB3-5 KVYGEARAKVAN 86 28
VB4-1 SPTSKYIEQIFKGTEYSGIDSET 85.7 24 100
VB4-2 KNSSDKIGKILGDTDGQNEKRKK 86 31
VB4-3 ENNSSDNIGKILGGDGDRKNEKRKA 88.3 45
VB5-1 KHAYGNISHDDKKKLDIPNNDNEH 86.1 10 97
VB5-2 QKGKNNTHSEKLDEAWCDLPMEGDIP 98.7 21
VB5-3 KQAGGYKETVEKLSEKKQKCTFPDIESVP 95.9 17
VB5-4 KQAGGDTKTNENCRFPDTDGVP 85.1 48
VB6-1 CTKRKELYEDVQKICASAECNTSNGSVDKAECTKTCVNYKN 98.4 11 80
VB6-2 CTRRNELYENMVTACNSAKCNTSNGSVDKKECTEACKEYSN 92.7 7
VB6-3 CVTRQELYDEVRTKCATAECTNGRINESECTQACDKYKN 84.2 15
VB6-4 CSHRKKLYEELNSACTSAECDTTNGTIGNNCTIACQEYSN 88.3 15
VB6-5 CVTRQELYDKLNSECISAECTNGSVDNSKCTHACVNYKN 89.7 11
VB6-6 CVTRQELYNDVKSACESGSCDTKKGKIDRADCESSCNKYKN 100 7
VB6-7 CTRRNELYKNMDNECKSAKCNKNDEGTGMTTCKRACQEYSN 90.2 7
VB6-8 CNNRYKELEKLKMSCPHNVCFLDEGTEKKCIEACEKYQN 94.9 7
VB7-1 QSLKSYYDVNYKETKGKNKEAHEFFKN 94.4 15 63
VB7-2 EIQKNKYDTEFKNQNGNDKDAPDYLKE 86.3 41
VB7-3 EIQKDIYDAKFKNKNGNHKDAPDYIKE 85.2 7
1average pairwise identity for sequences within this consensus group. Sequences with 85% or greater pairwise identity were considered the same consensus group
based on ELISA reactivity in Figure 7.
*Percentage of parasites presenting a consensus sequence with average percent pairwise identity.
&Percentage of parasites presenting one of the listed consensus sequences at this given VB.
doi:10.1371/journal.pone.0011276.t004
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cells were used for protein expression. The recombinant protein was
secreted in the XPress medium, harvested, and dialyzed against
20 mM Tris (pH 7.5) and 500 mM NaCl. After equilibration with
dialysed buffer, the Talon gel (Clontech; BectonDickinson) was
incubated with the dialysed protein, packed in a HR5-5 GE
Healthcare column, washed with 20 ml of dialysis buffer and eluted
with the same buffer plus 0.3 M imidazole. Fractions were pooled
and concentrated in an YM-10 Centricon column (Amicon;
Millipore) and a volume of 2mL was injected at 0.6 ml min
21 on
a high-load 16/60 Superdex 200 column (GE Healthcare) pre-
equilibrated in 20mM Tris–HCl (pH 7.5), 0.5M NaCl, and the
absorption was followed at 280 nm.Fractions from75 to 82 mlwere
collected, pooled and concentrated. Concentration was estimated
using the calculated extinction coefficient (1.553 mg/mL/OD280)
determined with http://www.expasy.ch/tools/protparam.html web
site. The calculated mass of the CYK48-DBL6e domain is
42.072 kDa and the theoretical pI is 8.28. Five mg of the purified
domain were loaded onto a 10% acrylamide gel run at 200V stained
with Coomassie blue, or transferred onto a nitrocellulose membrane
and incubated with an anti His-tag HRP coupled antibody (Roche).
The revelation was done using of an ECL kit (GE Healthcare).
Biotinylated peptides allowed coating of a constant quantity
and steric hindrance was minimised by the presence of an arm
of an e-aminohexanoic acids (Ahx) and two glycin residues
(except for peptide representing VB7 without glycin), permitting
a better epitope presentation and a potentially more
efficient antibody recognition. All peptides were synthesised by
Genepep.
Model of DBL6e structure
The 3D-model was calculated with HHpred (http://toolkit.
tuebingen.mpg.de/hhpred) and the sequence of CYK48-DBL6e
domain was aligned within the structure of DBL6e (2WAU)
[35] with default settings. Pictures have been generated with
MacPyMOL.
ELISA responses of plasma samples or purified IgG
against CYK48-DBL6e or peptides
The specific response directed against the purified recombinant
CYK48-DBL6e domain was assessed in plasma samples from 52
multigravid and 28 primigravid women from Senegal, eight
plasma samples from men, and eight from women, both living in
non-endemic area. 96-well plates (maxisorp, NUNC) were coated
with 100 mL of 0.5 mg/mL of antigen diluted in PBS and
incubated over night at 4uC. After 3 washing steps with washing
buffer (1% Tween 20 in PBS), wells were blocked with blocking
buffer (2% BSA, 0.1% Tween 20 in PBS) and after 3 washing
steps, they were incubated with 100 mL of human plasma samples
(1:400) diluted in blocking buffer, followed by horseradish
peroxidase-conjugated anti–human IgG (1:4000). TMB was added
and the reaction was stopped after 15 minutes with 50ml of 0.25M
H2SO4. The optical density (OD) was read at 450 nm, and final
values were obtained by subtracting the average OD of duplicate
wells from that of the corresponding blank wells coated with BSA
0.5 mg/mL in PBS.
We performed a similar ELISA assay with various IgG
concentrations to check the response of positive and negative
plasma. The results were analyzed using the Kaleidagraph
software according a hyperbolic saturation curve to determine
the apparent avidity constant (Kapp) using the following
equation: (ODmax2ODmin)*(C/Kapp+C)+ODmin where OD
was determined at maximum and minimum purified IgG
concentrations and C was the IgG concentration used. ELISA
assays were carried out in duplicate. Ninety-six purified IgG
responses against 7 peptides mimicking the seven variable blocks
present within the CYK48-DBL6e domain were measured. IgG
was purified by incubating 30 ml of plasma samples on protein G
columns to prevent from saturation and to determine the exact
amount of IgG present in the plasma. Ninety-six-well plates
coated with streptavidine (NUNC) were incubated with 200mL
of blocking buffer (0.5% milk, 0.1% Tween 20 in PBS) at room
temperature for one hour and washed 3 times (PBS, 0.1%
Tween 20). A volume of 100 mL containing 3.10
211 moles of
each peptide diluted in PBS was incubated for one hour at room
temperature followed by 3 washing steps. One hundred mLo f
IgG at a concentration of 0.0205 g/L and diluted in blocking
buffer were incubated for 90 min at 18uC. After 3 washing
steps, horseradish peroxidase-conjugated anti–human IgG
(1:3500) was incubated for one hour at room temperature.
TMB was added and reaction was stopped by adding with 30ml
of 0.25M H2SO4.
Table 5. Sequences and percentage of identity of loop 5 from isolates.
Isolates Sequences of VB number 5 %APPI* IgG reactivity
$ Gestity
CYK48 KQAGGYKETVEKLSEKKQKCTFPDIESVP 100 2 2
PAL10 KQAGGYKETVEKLSEKKQKCTFPDIESVP ++ 3
PAL09 KQAGGDTKTNENCRFPDTDGVP 80.5 2 6
CYK32 KEGGGDLSNNENCRFPDTDGVP 2 1
CYK30 KQAGGDTKTNENCRFPDTDGVP ++ 1
CYK24 KQAGGDTKTNENCRFPSIESVS 2 1
CYK37 KQAGGDTETNENCRFPDTDGVP + 4
CYK58 QKGKNNTHSEKLDEAWCDLPMEGDIP 100 +++ 2
CYK49 QKGKNNTHSEKLDEAWCDLPMEGDIP ++ 2
CYK51 QKGKNNTHSEKLDEAWCDLPMEGDIP 2 7
CYK57 KHAYGNISHDDKKKLDIPNNDNEH 86.1 ++ 1
*Average percent pairwise identity.
$To the VB5 of CYK48-DBL6e.
Sequences of the various VB5 of isolates to be compared with their IgG reactivity.
doi:10.1371/journal.pone.0011276.t005
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